Thursday, June 26, 2014

Top China Stocks To Own For 2015

Top China Stocks To Own For 2015: Mindray Medical International Limited (MR)

Mindray Medical International Limited, through its subsidiary, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., develops, manufactures, and markets medical devices worldwide. It operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. The Patient Monitoring and Life Support Products segment offers patient monitoring devices that track the physiological parameters of patients, such as heart rate, blood pressure, respiration, and temperature. This segment?s patient monitoring devices are suitable for adult, pediatric, and neonatal patients and are used principally in hospital intensive care units, operating rooms, and emergency rooms. This segment provides single and multiple-parameter monitors, mobile and portable multifunction monitors, central stations that could collect and display multiple patient data on a single screen, and an electro-cardiogram monitoring device; veterinary monitoring devi ces; and anesthesia machines, as well as defibrillators, surgical beds, and surgical lights. The In-Vitro Diagnostic Products segment offers data and analysis on blood, urine, and other bodily fluid samples for clinical diagnosis and treatment. This segment also provides semi-automated and fully-automated in-vitro diagnostic products for laboratories, clinics, and hospitals. In addition, this segment offers hematology analyzers and biochemistry analyzers, and reagents. The Medical Imaging Systems segment provides ultrasound systems, which are employed in medical fields consisting of urology, gynecology, obstetrics, and cardiology; digital radiography systems; and a magnetic resonance imaging system. The company serves distributors, original design manufacturers, original equipment manufacturers, and hospitals and government agencies. Mindray Medical International Limited was founded in 1991 and is headquartered in Shenzhen, the People?s Republic ! of China..

Advisors' Opinion:
  • [By John Udovich]

    China is set to ease the one child policy, something that could benefit Chinese stocks in general but be especially beneficial to insurance stocks like China Life Insurance Company Ltd (NYSE: LFC) and CNinsure Inc (NASDAQ: CISG) plus health care stocks like Mindray Medical International Ltd(NYSE: MR) and Concord Medical Services Hldg Ltd (NYSE: CCM). First, lets be clear that China is NOT abolishing the one child policy as the changes will merelyallow married couples to have two children if one spouse is an only child plus it will be up to Chinas 34 province-level administrations to revisetheir laws and put the new policy into effect. Moreover, Chinas family-planning bureaucracy employs more than 500,000 full-time workers and six million part-time workers all the way down to the village level tocollect billions of dollars in fines and these bureaucrats have fought for years against policy changes meaning they could throw up roadblocks if not placated. With that said, the insurance and health care sectors are two sectors with publicly Chinese stocks that look set totake advantage of the coming changes.

  • [By Rich Duprey]

    Medical device manufacturer Mindray Medical (NYSE: MR  ) announced this morning that it has appointed a co-CEO for the company.

    Cheng Minghe, who currently serves asthe company's chief strategic officer -- a position he will maintain -- will join company PresidentLi Xiting in leading the device maker.

  • [By Keith Speights]

    It's easy to place too much attention on the immediate negatives and too little attention on the bigger positives. I made this mistake in 2011 after buying shares in Mindray Medical (NYSE: MR  ) . I ended up selling my shares for a loss when the stock fell due to weaker-than-expected demand for its medical devices in Europe and the U.S.

  • source from Top P! enny Stock! s For 2015:http://www.seekpennystocks.com/top-china-stocks-to-own-for-2015.html

No comments:

Post a Comment